Bipolar Disorder Trial, Recruiting NCT06555406 Sponsor: University of California, Berkeley Condition: Bipolar Disorder
Back to Bipolar Disorder

Bipolar Disorder Trial, Recruiting

NCT06555406
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with bipolar I disorder or bipolar II disorder (not other related conditions such as cyclothymia), confirmed through a structured diagnostic interview used by the study team
  • People who are currently experiencing sleep problems, such as trouble sleeping, sleeping too much, or having a shifted or irregular body clock schedule
  • People living in an English-speaking country where the research team has experience conducting studies
  • People who have spoken English for at least 10 years, speak English at home, or can demonstrate a strong understanding of English during the screening interview
  • People who are currently receiving medical care for bipolar disorder (the trial site can provide referrals for those who wish to start care)
  • People whose mood-stabilising medications have remained unchanged for at least one month
  • People whose weight has changed by less than 5 kg over the past three months
  • People who are currently eating across a period of 12 hours or more per day on at least two days per week
  • People who are able to use a smartphone camera and complete online surveys (loaner phones may be available if needed)
  • People who do not work shift work and do not have responsibilities, such as caring for others, that regularly disrupt their sleep during overnight hours
  • People who are able to complete seven days of food diary entries during the initial study period, with at least two entries per day covering a five-hour or longer eating window
  • People who are able to complete screening and baseline questionnaires carefully and thoroughly, as assessed by the study team

Who may not be able to join:

  • People currently experiencing a mood episode, such as depression, hypomania, mania, or psychosis (the trial site encourages these individuals to seek treatment and to consider the study once symptoms have settled)
  • People who have ever been diagnosed with or treated for an eating disorder, or whose current questionnaire responses suggest eating disorder concerns
  • People who have experienced alcohol use disorder or substance use disorder in the past three months
  • People with active thoughts of suicide combined with a plan, intent, or a history of a suicide attempt, as assessed by a standard rating scale
  • People with conditions that could interfere with taking part in the study, including pregnancy, breastfeeding, untreated thyroid problems, or digestive conditions that affect how the body absorbs nutrients
  • People with certain health conditions that could affect the study's measurements, such as HIV, AIDS, lupus, or multiple sclerosis
  • People taking certain medications that are not compatible with fasting, including clozapine, blood sugar-lowering medications, diabetes injections, corticosteroids, or medications that must be taken with food at specific times of day (confirm with trial site regarding specific medications)
  • People with cognitive difficulties identified during the initial interview or through a short memory and thinking assessment used by the study team

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Sheri L Johnson, PhD, University of California, Berkeley

Phone: (510) 519-4305

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University of California, Berkeley
Registry
ClinicalTrials.gov
Start date
22 November 2024
Est. completion
1 February 2029

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Mania; Depression; Self-rated Quality of Life (QOL)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov